Skip to content
← Full study record

NCT06263582 · MORE INFO

Limitations, agreements, and source contact

Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya · Source last updated 2025-08-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Pharmacokinetic (PK) sampling from 0 to 8 hours after intravaginal administration of artesunate was not sufficient to capture the elimination phase of the drug and its metabolite. As a result, key plasma pharmacokinetic parameters including apparent clearance (CL/F), apparent volume of distribution (Vd/F), elimination half-life (t½), and area under the concentration-time curve from time zero to infinity (AUC₀-∞) could not be estimated.
point Of Contact
email
kasorgi@email.unc.edu
organization
UNC Lineberger Comprehensive Cancer Center
phone
919-966-5280
title
Sorgi Kate
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Pharmacokinetic (PK) sampling from 0 to 8 hours after intravaginal administration of artesunate was not sufficient to capture the elimination phase of the drug and its metabolite. As a result, key plasma pharmacokinetic parameters including apparent clearance (CL/F), apparent volume of distribution (Vd/F), elimination half-life (t½), and area under the concentration-time curve from time zero to infinity (AUC₀-∞) could not be estimated.
point Of Contact
email
kasorgi@email.unc.edu
organization
UNC Lineberger Comprehensive Cancer Center
phone
919-966-5280
title
Sorgi Kate

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice